First Time Loading...

Schrodinger Inc
NASDAQ:SDGR

Watchlist Manager
Schrodinger Inc Logo
Schrodinger Inc
NASDAQ:SDGR
Watchlist
Price: 25.07 USD -1.53% Market Closed
Updated: Apr 18, 2024
Section:
 

Relative Value

The Relative Value of one SDGR stock under the Base Case scenario is 17.07 USD. Compared to the current market price of 25.07 USD, Schrodinger Inc is Overvalued by 32%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SDGR Relative Value
Base Case
17.07 USD
Overvaluation 32%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

8.3
P/S
P/S
Price to Sales
8.3
vs History
90
vs Industry
16
Median 3Y
12.1
Median 5Y
17.2
Industry
2.4
Forward
8.6
More Details
44.4
P/E
P/E
Price to Earnings
44.4
vs History
21
vs Industry
11
Median 3Y
-12
Median 5Y
-16.8
Industry
23.4
Forward
-8.7
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
3
Median 3Y
-18.8
Median 5Y
-20.8
Industry
15.5
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
4
Median 3Y
-17.1
Median 5Y
-19.3
Industry
23.5
More Details
3.3
P/B
P/B
Price to Book Value
3.3
vs History
88
vs Industry
27
Median 3Y
4.2
Median 5Y
4.6
Industry
2.3
More Details
6.2
EV/S
EV/S
Enterprise Value to Sales
6.2
vs History
90
vs Industry
20
Median 3Y
9.8
Median 5Y
13.4
Industry
2.5
Forward
6.4
More Details
9.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
9.6
vs History
90
vs Industry
23
Median 3Y
17.6
Median 5Y
26.1
Industry
5.3
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-12.3
Median 5Y
-17.6
Industry
12.6
Forward
-6.6
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-12
Median 5Y
-17.1
Industry
17.1
Forward
-6.3
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
4
Median 3Y
-14.8
Median 5Y
-15.5
Industry
15
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
5
Median 3Y
-13.5
Median 5Y
-14.3
Industry
19.6
More Details
4.2
EV/IC
EV/IC
Enterprise Value to IC
4.2
vs History
92
vs Industry
21
Median 3Y
7.5
Median 5Y
10.9
Industry
2
More Details

Multiples Across Competitors

SDGR Competitors Multiples
Schrodinger Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Schrodinger Inc
NASDAQ:SDGR
1.8B USD 8.3 44.4 -7.8 -7.6
US
Veeva Systems Inc
NYSE:VEEV
32.3B USD 13.7 61.4 61.2 65.8
US
Cerner Corp
NASDAQ:CERN
27.9B USD 4.8 47.3 19.6 38.6
US
Change Healthcare Inc
NASDAQ:CHNG
9B USD 2.6 -116.8 16.5 111.6
JP
M3 Inc
TSE:2413
1.3T JPY 5.4 27.6 14.6 16.5
US
Inspire Medical Systems Inc
NYSE:INSP
7.1B USD 11.4 -337.4 -178.4 -165.8
AU
Pro Medicus Ltd
ASX:PME
10.5B AUD 71.6 150.1 103.1 103.1
US
Doximity Inc
NYSE:DOCS
4.7B USD 10 34.1 23 24.5
SE
Sectra AB
STO:SECT B
40.4B SEK 24.7 95.2 -62.6 -62.6
US
Evolent Health Inc
NYSE:EVH
3.4B USD 1.7 -23.7 27.7 295.4
US
Vocera Communications Inc
NYSE:VCRA
2.8B USD 11.7 -324 264.4 4 233.4
P/E Multiple
Earnings Growth
US
Schrodinger Inc
NASDAQ:SDGR
Average P/E: 65.7
44.4
N/A
US
Veeva Systems Inc
NYSE:VEEV
61.4
139%
US
Cerner Corp
NASDAQ:CERN
47.3
N/A
US
Change Healthcare Inc
NASDAQ:CHNG
Negative Multiple: -116.8 N/A
JP
M3 Inc
TSE:2413
27.6
26%
US
Inspire Medical Systems Inc
NYSE:INSP
Negative Multiple: -337.4 N/A
AU
Pro Medicus Ltd
ASX:PME
150.1
119%
US
Doximity Inc
NYSE:DOCS
34.1
79%
SE
Sectra AB
STO:SECT B
95.2
56%
US
Evolent Health Inc
NYSE:EVH
Negative Multiple: -23.7 N/A
US
Vocera Communications Inc
NYSE:VCRA
Negative Multiple: -324 N/A
EV/EBITDA Multiple
EBITDA Growth
US
Schrodinger Inc
NASDAQ:SDGR
Average EV/EBITDA: 66.3
Negative Multiple: -7.8 		N/A
US
Veeva Systems Inc
NYSE:VEEV
61.2
224%
US
Cerner Corp
NASDAQ:CERN
19.6
N/A
US
Change Healthcare Inc
NASDAQ:CHNG
16.5
N/A
JP
M3 Inc
TSE:2413
14.6
29%
US
Inspire Medical Systems Inc
NYSE:INSP
Negative Multiple: -178.4 N/A
AU
Pro Medicus Ltd
ASX:PME
103.1
121%
US
Doximity Inc
NYSE:DOCS
23
102%
SE
Sectra AB
STO:SECT B
Negative Multiple: -62.6 N/A
US
Evolent Health Inc
NYSE:EVH
27.7
193%
US
Vocera Communications Inc
NYSE:VCRA
264.4
N/A
EV/EBIT Multiple
EBIT Growth
US
Schrodinger Inc
NASDAQ:SDGR
Average EV/EBIT: 611.1
Negative Multiple: -7.6 		N/A
US
Veeva Systems Inc
NYSE:VEEV
65.8
241%
US
Cerner Corp
NASDAQ:CERN
38.6
N/A
US
Change Healthcare Inc
NASDAQ:CHNG
111.6
N/A
JP
M3 Inc
TSE:2413
16.5
N/A
US
Inspire Medical Systems Inc
NYSE:INSP
Negative Multiple: -165.8 N/A
AU
Pro Medicus Ltd
ASX:PME
103.1
108%
US
Doximity Inc
NYSE:DOCS
24.5
115%
SE
Sectra AB
STO:SECT B
Negative Multiple: -62.6 N/A
US
Evolent Health Inc
NYSE:EVH
295.4
2 192%
US
Vocera Communications Inc
NYSE:VCRA
4 233.4
N/A

See Also

Summary
SDGR intrinsic value, competitors valuation, and company profile.
DCF Valuation
SDGR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SDGR stock valuation using valuation multiples.
Wall Street Estimates
SDGR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SDGR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 129,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.